Earnings Estimates

Glossary »

Stock Information

Price (Prev Close) 123.22
Price - 52 Week High 127.64
Price - 52 Week Low 94.42
Price Date (Latest) Mar 24, 2017
Median Price Target 143.00
Diff from Prev Close 19.78
% Difference 16.05%

 

Analyst Ratings

1 Strong Buy 12
2 Buy 12
3 Hold 4
4 Underperform 1
5 Sell 0

Mean Recommendation: 1.79

Reference Information

Last Actual (FY0) 5.94
FY0 End Date Dec '16
Indicated Annual Div. N/A
Hist (5 Yr) Growth % 26.72 %
Hist (5 Yr) Stability % 3.34 %
Yield (%) N/A

 

Analyst Forecasts

Last Month Revisions
Fiscal Period Mean High Low Median # of Estimates # Up # Down Mean % Change
Annual
Dec '19
10.57 11.85 9.12 10.60 19 1 3 -0.21 %
Annual
Dec '18
8.77 9.63 7.88 8.73 27 2 1 0.10 %
Annual
Dec '17
7.22 7.55 7.12 7.22 28 0 2 0.03 %
Quarterly
Mar '17
1.63 1.86 1.46 1.62 23 0 1 0.10 %
Quarterly
Jun '17
1.76 1.85 1.68 1.76 23 0 1 0.17 %
Quarterly
Sep '17
1.87 2.00 1.77 1.87 23 0 1 -0.00 %
Quarterly
Dec '17
1.96 2.10 1.85 1.97 23 1 1 -0.05 %
Long Term Growth
N/A
22.28 25.00 16.00 23.00 11 0 2 -  

 

Actuals

Fiscal Period Reported EPS Mean Estimate Surprise % Change
Annual
Dec '16
5.94 5.92 0.27 %
Quarterly
Mar '16
1.32 1.27 3.53 %
Quarterly
Jun '16
1.44 1.38 3.98 %
Quarterly
Sep '16
1.58 1.48 6.85 %
Quarterly
Dec '16
1.61 1.59 0.97 %
Annual
Dec '15
4.71 4.76 -0.95 %
Annual
Dec '14
3.71 3.69 0.52 %

 

P/E Ratios

Celgene Corporation - biotechnology

Fiscal Period Celgene Corporation biotechnology Industry Relative
FY0 17.76 42.65 0.42
FY1 14.60 45.48 0.32
FY2 12.03 31.68 0.38

 

Growth Rates

Celgene Corporation - biotechnology

Fiscal Period Celgene Corporation biotechnology Industry Relative
FY1/FY0 21.62 -5.51 1.29
FY2/FY1 21.34 39.71 0.87
FY3/FY2 20.58 43.89 0.84

Disclaimer: Mean earnings estimates are calculated by First Call based on their earnings projections made by the analysts who cover Celgene Corporation. Please note that any opinions, estimates or forecasts regarding Celgene Corporation's performance made by these analysts (and therefore the average estimate numbers) are theirs and do not represent opinions, forecasts or predictions of Celgene Corporation or its management. Celgene Corporation does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Prices are in USD